Dx4LMICs conference Philip Fowler, 3rd July 20243rd July 2024 The whole group attended the second Diagnostics for LMICs conference at Reuben College on 2-3 July 2024. Was an unusually diverse meeting with talks ranging from lateral flow devices, including recent innovations like nano-diamonds to dramatically increase sensitivity, a study showing the forehead thermometers are not very accurate, work to reduce neonatal sepsis in Malawi and Zimbabwe and a session on tuberculosis. Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related group meetings
Viki Brunner wins poster prize 23rd November 202223rd November 2022 The whole group attended the first INEOS Oxford Institute meeting on Multidisciplinary Approaches to AMR… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
group Congratulations Dr Brankin! 21st January 202321st January 2023 Alice successfully defended her thesis “Predicting Fluoroquinolone Resistance in Mycobacterium tuberculosis” yesterday. Her examiners were Professor… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance Diagnosing antibiotic resistance: future trends? 23rd April 20175th August 2018 It is Sunday, I’m in Vienna at the European Congress of Clinical Microbiology and Infectious… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More